PLC (NASDAQ:SMX)(NASDAQ:SMXWW), a global pioneer in digitizing physical objects for a circular economy, today announced the ...
Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event ...